|Articles|February 15, 2003
- BioPharm International-02-01-2003
- Volume 16
- Issue 2
Inside Washington: AIDS Prevention Campaign Spotlights Biotech
Author(s)Jill Wechsler
by Jill Wechsler Efforts to move vaccines from test stage to commercial production are raising concerns about manufacturing capacity.
Advertisement
Articles in this issue
over 22 years ago
Becoming a Partner of Choice and Evaluating Prospective Alliancesover 22 years ago
Guest Editorial: Maybe You Need a Corporate Marriage Counselorover 22 years ago
Survival Strategies: Keeping Tabs on Trainingover 22 years ago
Outsourcing Outlook: Contract Services' Crystal BallNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
5
